| Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults (NCT05881213) | Chong Kun Dang Pharmaceutical | 2023-06-01 |
| Implantation Of Vaginal Construct For Patients With Vaginal Aplasia (NCT05675722) | Wake Forest University Health Sciences | 2023-06-01 |
| XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma (NCT05927844) | Fujian Cancer Hospital | 2023-06-01 |
| MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma (NCT05655312) | Perspective Therapeutics | 2023-06-01 |
| Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer (NCT05882630) | Fujian Cancer Hospital | 2023-06-01 |
| Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma (NCT05938387) | CureVac | 2023-06-01 |
| A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers (NCT05851066) | Visirna Therapeutics HK Limited | 2023-06-01 |
| Cluster Randomised Control Trial of the BodyKind Body Image Programme (NCT06076993) | University College Dublin | 2023-06-01 |
| A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection (NCT05865574) | Bio-Thera Solutions | 2023-06-01 |
| EO4010 in Previously Treated Metastatic Colorectal Carcinoma (NCT05589597) | Enterome | 2023-06-01 |
| A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel (NCT04252768) | Immutep S.A.S. | 2023-06-01 |
| EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer (NCT05498389) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2023-06-01 |
| Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals (NCT05786937) | University of Sao Paulo General Hospital | 2023-06-01 |
| This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition. (NCT05823883) | Dong Wha Pharmaceutical Co. Ltd. | 2023-06-01 |
| A PK Study to Assess the Drug-drug Interaction of a Strong CYP2C8 Inhibitor on Adagrasib (NCT05868356) | Mirati Therapeutics Inc. | 2023-06-01 |
| Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat (NCT06247462) | University of New Mexico | 2023-06-01 |
| Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers (NCT05894707) | Sinocelltech Ltd. | 2023-06-01 |
| Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration (NCT05788900) | Blau Farmaceutica S.A. | 2023-06-01 |
| Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B (NCT05905731) | Beijing 302 Hospital | 2023-06-01 |
| Safety and Tolerability of Intravenous Administration of ICVB-1042 (NCT05904236) | IconOVir Bio | 2023-06-01 |
| Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine (NCT05706324) | Wuhan BravoVax Co., Ltd. | 2023-06-01 |
| A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218 (NCT05844228) | Vir Biotechnology, Inc. | 2023-06-01 |
| A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer (NCT06938711) | Context Therapeutics Inc. | 2023-06-01 |
| NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors (NCT05881525) | TCRCure Biopharma Ltd. | 2023-06-01 |
| Targeting Senescence to Reduce Osteoarthritis Pain and cartilagE Breakdown (ROPE) (NCT04770064) | Austin V Stone | 2023-06-01 |
| Bioavailability Study of Psilocybin in Normal Adults (NCT05467761) | University of Wisconsin, Madison | 2023-06-01 |
| Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration (NCT05788913) | Blau Farmaceutica S.A. | 2023-06-01 |
| Evaluation of the Colonization Capacity of a Probiotic Bacterium. (NCT05878444) | Valencian Innovation Agency | 2023-06-01 |
| De-escalation of Ticagrelor in Post PPCI (NCT05831462) | Assiut University | 2023-06-01 |
| Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis (NCT05906433) | Foundation for Orthopaedic Research and Education | 2023-06-01 |
| Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung Cancer (NCT05171062) | The University of Texas Health Science Center at San Antonio | 2023-06-01 |
| Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer (NCT05705466) | Kartos Therapeutics, Inc. | 2023-06-01 |
| Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture (NCT05883241) | ZetrOZ, Inc. | 2023-06-01 |
| Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type II (NCT05665166) | University of Manchester | 2023-06-01 |
| Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer (NCT05766748) | Cantex Pharmaceuticals | 2023-06-01 |
| To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. (NCT05859373) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-06-01 |
| Investigating the Use of a Brain-computer Interface Based on TMS Neurofeedback for Upper Limb Stroke Rehabilitation (NCT06164912) | University of Dublin, Trinity College | 2023-06-01 |
| Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection (NCT06018363) | Dushu Lake Hospital Affiliated to Soochow University | 2023-06-01 |
| B7-H3 CAR-T for Recurrent or Refractory Glioblastoma (NCT04077866) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-06-01 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine Candidate (NCT05863585) | International AIDS Vaccine Initiative | 2023-06-01 |
| Low-dose IL-2 in Established T1D - The "PROREG" Study (NCT03243058) | Jay S. Skyler | 2023-06-01 |
| Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children (NCT05937191) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-06-01 |
| Tramadol to Improve Its Detection in Biological Matrices in Anti-doping Controls (NCT05925686) | Parc de Salut Mar | 2023-06-01 |
| A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster (NCT05609045) | Wuhan Rhegen Biotechnology Co., Ltd. | 2023-06-01 |
| Radiological Evaluation of the Penis Before and After a Botox Injection (NCT06044883) | Cairo University | 2023-06-01 |
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors (NCT05864144) | Sensei Biotherapeutics, Inc. | 2023-05-31 |
| Single Ascending Dose Study of WAL0921 in Healthy Subjects (NCT05891366) | Walden Biosciences | 2023-05-31 |
| A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants (NCT05852769) | Bristol-Myers Squibb | 2023-05-31 |
| The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque (NCT05622877) | Guangzhou University of Traditional Chinese Medicine | 2023-05-31 |
| Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells (NCT05774509) | Assistance Publique - Hôpitaux de Paris | 2023-05-31 |
| A Phase Ia Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of EA5 in Healthy Adult Subjects (NCT07256288) | Shanghai Lanyi Therapeutics Co., Ltd. | 2023-05-31 |
| Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers (NCT05860296) | SignalChem Lifesciences Corporation | 2023-05-31 |
| UB-312 in Patients With Synucleinopathies (NCT05634876) | NYU Langone Health | 2023-05-31 |
| A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B (NCT05845645) | UCB Biopharma SRL | 2023-05-31 |
| SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People (NCT06048393) | Sinovac Life Sciences Co., Ltd. | 2023-05-31 |
| A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL) (NCT05879744) | Cullinan Therapeutics Inc. | 2023-05-31 |
| Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma (NCT05900089) | Henan Cancer Hospital | 2023-05-30 |
| TIL for Patients With Advanced Solid Tumor (NCT06334783) | Hervor Therapeutics | 2023-05-30 |
| A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) (NCT05824975) | GI Innovation, Inc. | 2023-05-30 |
| Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index (NCT05946122) | Minia University | 2023-05-30 |
| Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI (NCT04954599) | Maastricht University Medical Center | 2023-05-30 |
| A Pharmacokinetic Study of JS002 in Healthy Subjects (NCT05859529) | Shanghai Junshi Bioscience Co., Ltd. | 2023-05-30 |
| A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants (NCT05896683) | Janssen Research & Development, LLC | 2023-05-30 |
| A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors (NCT05765851) | Daiichi Sankyo | 2023-05-30 |
| A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease (NCT05335161) | Purdue University | 2023-05-30 |
| CART-38 in Adult AML and MM Patients (NCT05442580) | University of Pennsylvania | 2023-05-30 |
| SG1906 for CLDN18.2-Positive Solid Tumors (NCT05857332) | Hangzhou Sumgen Biotech Co., Ltd. | 2023-05-30 |
| Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults (NCT05935917) | Emergent BioSolutions | 2023-05-30 |
| Vaccine Response With NT-I7 (NCT04054752) | National Cancer Institute (NCI) | 2023-05-30 |
| Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy (NCT05884268) | Mansoura University | 2023-05-30 |
| A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022 (NCT05912296) | Suzhou Ribo Life Science Co. Ltd. | 2023-05-30 |
| A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy (NCT05942508) | Jinming Yu | 2023-05-30 |
| Phase I Trial of Envafolimab for Healthy Male Subjects (NCT05849311) | 3D Medicines (Sichuan) Co., Ltd. | 2023-05-29 |
| Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas (NCT05809830) | Grupo Espanol de Investigacion en Sarcomas | 2023-05-29 |
| To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability (NCT05856058) | Jiangsu HengRui Medicine Co., Ltd. | 2023-05-29 |
| A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin (NCT06112808) | Biocad | 2023-05-29 |
| SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects (NCT06678581) | Shanton Pharma Co., Ltd. | 2023-05-29 |
| A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics (NCT05969977) | MED-LIFE DISCOVERIES LP | 2023-05-29 |
| Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome (NCT06737666) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2023-05-29 |
| Diode Laser Photo Activation for Pocket Reduction Decontamination A Clinical Study (NCT06404190) | Krishnadevaraya College of Dental Sciences & Hospital | 2023-05-28 |
| To Evaluate the Safety and the Pharmacokinetics of NVP-2203 (NCT05725252) | NVP Healthcare | 2023-05-28 |
| Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma (NCT05646082) | Imperial College London | 2023-05-26 |
| A Study of MHB036C for Advanced Solid Tumor (NCT06373406) | Minghui Pharmaceutical (Hangzhou) Ltd | 2023-05-26 |
| Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers (NCT05921591) | Revolo Biotherapeutics | 2023-05-26 |
| Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150 (NCT05816759) | Chong Kun Dang Pharmaceutical | 2023-05-26 |
| A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants. (NCT05644600) | AstraZeneca | 2023-05-26 |
| Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors (NCT05732831) | Tango Therapeutics, Inc. | 2023-05-26 |
| Single and Multiple Ascending Dose Study of AER-01 (NCT05862623) | Aer Therapeutics | 2023-05-26 |
| Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors (NCT05851092) | Shandong Suncadia Medicine Co., Ltd. | 2023-05-26 |
| Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma (NCT05834543) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-05-26 |
| A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine (NCT05871541) | Immorna Biotherapeutics, Inc. | 2023-05-26 |
| Daratumumab in Primary Antiphospholipid Syndrome (NCT05671757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-26 |
| A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) (NCT05885464) | Beam Therapeutics Inc. | 2023-05-25 |
| A Study of PER-001 in Participants With Open-Angle Glaucoma (NCT05822245) | Perfuse Therapeutics, Inc. | 2023-05-25 |
| A Study of TAS3351 in NSCLC Patients With EGFRmt (NCT05765734) | Taiho Oncology, Inc. | 2023-05-25 |
| A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus (NCT05687526) | RemeGen Co., Ltd. | 2023-05-25 |
| A Study of TAK-227 in Healthy Adults (NCT05818956) | Takeda | 2023-05-25 |
| LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML (NCT05548088) | Peking University People's Hospital | 2023-05-25 |
| Hydroxyurea and EPO in Sickle Cell Disease (NCT05451940) | Julia Xu | 2023-05-25 |
| Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers (NCT05905653) | Santen Pharmaceutical Co., Ltd. | 2023-05-25 |